BREAST CARCINOMA IN SITU
Clinical trials for BREAST CARCINOMA IN SITU explained in plain language.
Never miss a new study
Get alerted when new BREAST CARCINOMA IN SITU trials appear
Sign up with your email to follow new studies for BREAST CARCINOMA IN SITU, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Keytruda aims to stop Triple-Negative breast cancer return in High-Risk patients
Disease control OngoingThis phase III trial tests whether adding pembrolizumab (Keytruda) after standard chemotherapy can help prevent triple-negative breast cancer from coming back. Over 1,100 patients with residual cancer after chemo are randomly assigned to receive pembrolizumab or placebo. The stud…
Matched conditions: BREAST CARCINOMA IN SITU
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 02, 2026 01:00 UTC
-
Could a skin gel help fight breast cancer? early trial tests endoxifen
Disease control OngoingThis early-phase trial is testing a gel form of the drug endoxifen, applied to the skin, in 32 women scheduled for breast surgery. The goal is to see if the gel is safe and how much of the drug gets into breast tissue and blood. If successful, it might offer a gentler way to trea…
Matched conditions: BREAST CARCINOMA IN SITU
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New combo therapy may help women with early breast cancer avoid mastectomy
Disease control ENROLLING_BY_INVITATIONThis study tests whether giving two drugs (trastuzumab and a taxane) before surgery can shrink HER2-positive breast carcinoma in situ tumors enough to allow breast-conserving surgery instead of mastectomy. About 54 women aged 18-70 with tumors at least 2 cm will receive 4-6 cycle…
Matched conditions: BREAST CARCINOMA IN SITU
Phase: PHASE2 • Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
7,000 samples donated to unlock breast cancer secrets
Knowledge-focused OngoingThis study collects blood, tissue, and saliva samples from 7,000 people—both those with breast cancer and healthy volunteers. Researchers at Memorial Sloan Kettering will use these samples to study what causes breast cancer and find better ways to prevent, detect, and treat it. N…
Matched conditions: BREAST CARCINOMA IN SITU
Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:08 UTC